Applikon Biotechnology, a private Dutch company specialized in the development, manufacture and supply of bioreactor systems for both research and production use, has started the construction of a new facility on the high-tech science park Technolopis in Delft. The building with offices, laboratories, a workshop and warehouse will accommodate approximately 100 people.
Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.
BASF sells a majority stake in its coatings business to the investor Carlyle.
Compelling solutions through strategic partnerships
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.
Novo Nordisk announced a global workforce reduction of approximately 9,000 positions to streamline operations and reinvest DKK 8 billion (€1 billion) in growth opportunities for diabetes and obesity treatments.
